Medicare Part B drug prices
Executive Summary
HHS Office of Inspector General identifies 34 Healthcare Common Procedure Coding System drug codes with first quarter 2007 average sales prices that exceeded average manufacturer prices by at least 5 percent, thus qualifying the drug products for price adjustments under Medicare Part B in a Sept. 18 report to CMS. Lowering reimbursement amount for the 34 products to 103 percent of the AMPs would reduce Medicare allowances by an estimated $9 million in third quarter, report estimates. The Medicare Modernization Act tasked OIG with comparing ASPs to AMPs for physician-administered drugs covered by Medicare Part B; report is third released so far by OIG (1"The Pink Sheet" July 17, 2006, p. 17)...
You may also be interested in...
WAMP-Based Part B Reimbursement For Five Drugs Could Save $67 Mil. – OIG
The HHS Office of Inspector General (OIG) contends that reimbursement for five Medicare Part B drugs is too high relative to their market prices and recommends that CMS lower payment levels for them
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.